Abstract: A drug carrier with thermal sensitivity, a manufacturing method thereof, and a use thereof are disclosed. The drug carrier comprises a nano-magnetic particle, a drug, a composite polymer, and a dense silica shell. The nano-magnetic particle and the drug are encapsulated in the composite polymer which is formed by self-assembly a water-soluble polymer (such as poly vinyl alcohol) and a thermosensitive copolymer (such as Pluronic F68 or Pluronic F127). The stability and drug release of the drug carrier a can be adjusted by combining PVA and thermosensitive copolymer with a different ratio. When an external magnetic field was applied, the cores exhibit significant size shrinkage and the diameter of the drug carrier decreases more than 10 folds due to the change of temperature, which causes burst-like drug release because of shell destruction and physical collapse of the drug carrier.

Abstract: A hollow sphere from amphiphilic chitosan derivatives and a method of preparing an amphiphilic chitosan derivative complex for medical use are disclosed, and the hollow sphere from amphiphilic chitosan derivatives comprises: chitosan derivatives represented by the following formula (I), which self-assemble and form a hollow sphere in a solvent; wherein, each R1 is independently hydrogen, C1˜C4 alkyl, C1˜C6 carboxyl, sulfate group, or phosphate group, each R2 is independently hydrogen, C1˜C12 alkyl, C1˜C6 carboxyl, or C2˜C12 acyl group, and m is an integer of 100-2000.

Abstract: A material is fabricated for capturing CO2 at mid-high temperature. The material is a layered material containing Ca, Al carbonates. A higher ratio of Ca to Al helps capturing CO2. The temperature for capturing CO2 is around 600° C. The material can even release CO2 at a high temperature. Thus, the material can process looping cycles of carbonation and decarbonization at a CO2 carbonation scale of 45% gCO2/g.

Abstract: Nanodevice and method for in vivo monitoring and release of drugs are provided. The disclosed nanodevice is characterized in having a drug-loaded nanosphere that is capable of releasing the encapsulated drugs upon magnetically stimulation. The nanodevice may also be used as a contrast agent for in vivo imaging and monitoring the concentration and distribution of the released drugs and/or active compounds injected separately into a target site of a subject.

Abstract: Nanodevice and method for in vivo monitoring and release of drugs are provided. The disclosed nanodevice is characterized in having a drug-loaded nanosphere that is capable of releasing the encapsulated drugs upon magnetically stimulation. The nanodevice may also be used as a contrast agent for in vivo imaging and monitoring the concentration and distribution of the released drugs and/or active compounds injected separately into a target site of a subject.

Abstract: Nanodevice and method for in vivo monitoring and release of drugs are provided. The disclosed nanodevice is characterized in having a drug-loaded nanosphere that is capable of releasing the encapsulated drugs upon magnetically stimulation. The nanodevice may also be used as a contrast agent for in vivo imaging and monitoring the concentration and distribution of the released drugs and/or active compounds injected separately into a target site of a subject.

Abstract: Microwave irradiation treatment is used to enhance the luminescent efficiency by improving surface morphology of the illuminating phosphors. The invention modifies the phosphor particles from the sheet-like shape into the spherical shape and so as to exhibit better crystalline property, thus it may provide for the fabrication of the phosphors with high luminescent efficiency for the optoelectronic devices.

Abstract: A material is fabricated for capturing CO2 at mid-high temperature. The material is a layered material containing Ca, Al carbonates. A higher ratio of Ca to Al helps capturing CO2. The temperature for capturing CO2 is around 600° C. The material can even release CO2 at a high temperature. Thus, the material can process looping cycles of carbonation and decarbonization at a CO2 carbonation scale of 45% gCO2/g.

Abstract: A hollow sphere from amphiphilic chitosan derivatives and a method of preparing an amphiphilic chitosan derivative complex for medical use are disclosed, and the hollow sphere from amphiphilic chitosan derivatives comprises: chitosan derivatives represented by the following formula (I), which self-assemble and form a hollow sphere in a solvent; wherein, each R1 is independently hydrogen, C1˜C4 alkyl, C1˜C6 carboxyl, sulfate group, or phosphate group, each R2 is independently hydrogen, C1˜C12 alkyl, C1˜C6 carboxyl, or C2˜C12 acyl group, and m is an integer of 100-2000.

Abstract: The invention discloses the synthesis and manufacturing of a novel core-shell nano-carrier with a drug-containing nanocomposite core surrounding with a single crystalline magnetic iron oxide shell. With a unique core-shell configuration, active agents such as drugs and biomolecules encapsulated in the core with an outer single-crystalline thin iron oxide shell can be perfectly protected from environmental damages and in the meantime, eliminating un-desirable release due to un-controllable diffusion of the active molecules from the nanocapsules during the course of delivery in patient's body, before reaching the disease sites.

Abstract: Microwave irradiation treatment is used to enhance the luminescent efficiency by improving surface morphology of the illuminating phosphors. The invention modifies the phosphor particles from the sheet-like shape into the spherical shape and so as to exhibit better crystalline property, thus it may provide for the fabrication of the phosphors with high luminescent efficiency for the optoelectronic devices.

Abstract: The present invention relates to a method for manufacturing a ferroelectric field-effect transistor, particularly to a ferroelectric field-effect transistor with a metal/ferroelectric/insulator/semiconductor (MFIS) gate capacitor structure. The method comprises steps of depositing a bismuth layered ferroelectric film on the insulator buffered Si, after a high-temperature thermal treatment, depositing an upper electrode on the bismuth layered ferroelectric film.

Abstract: The present invention relates to a method for manufacturing a ferroelectric field-effect transistor, particularly to a ferroelectric field-effect transistor with a metal/ferroelectric/insulator/semiconductor (MFIS) gate capacitor structure. The method comprises steps of depositing a bismuth layered ferroelectric film on the insulator buffered Si, after a high-temperature thermal treatment, depositing an upper electrode on the bismuth layered ferroelectric film.

Abstract: Disclosed herein is an SOG (Spin on Glass) material for spacer anodic bonding, which includes: 0.1˜3 wt % of tetraethyl orthosilicate (TEOS); 0.1˜5 wt % of methyl triethyl orthosilicate (MTEOS); 20˜30 wt % of ethanol; 0.1˜2 wt % of acetic acid solution containing alkali metal ions; and 0.1˜10 wt % of water. The solid content of alkali metal elements in the acetic acid solution containing alkali metal ions is 5%˜60%, and the pH value of the SOG material is 4˜6.

Abstract: A precursor composition of TiO2 doped with erbium (Er) and yttrium (Y) for forming a film used in a planar optical waveguide amplifier. The precursor composition includes 100 mol % TiO2 precursor compound, about 0.1-10 mol % erbium ion (Er3+) precursor compound, and about 1-50 mol % yttrium ion (Y3+) precursor compound, thereby forming a doped TiO2 film co-doped with erbium and yttrium an amorphous structure to achieve the enhancing effect on photoluminescence properties.

Abstract: A dielectric ceramic material is provided. The ceramic material includes a mixture represented by the formula of Bi2−x(Zn2/3Nb4/3)O7−3x/2(BZN), 0≦x≦0.67, and a flux having an eutectic composition for lowering the sintering temperature of the mixture from 950˜1100° C. to 800˜850° C. The dielectric material has a dielectric constant larger than 45 (∈r>45) and a quality factor larger than 1200 (or Q·f>4500) at 3.5 GHz.

Abstract: A doped TiO2 material for forming a film used in a planar optical waveguide amplifier. The doped TiO2 material includes 100 mol % TiO2 precursor compound, 0.1˜10 mol % erbium ion (Er3+) precursor compound, and 1˜50 mol % yttrium ion (Y3+) precursor compound, thereby forming the doped TiO2 film co-doped with erbium and yttrium as an amorphous structure to achieve the enhancing effect on photoluminescence properties.